Search clinical trials for: Influenza Human

Total 24843 results

University of Alabama at Birmingham

Active, not recruiting

Live Attenuated Influenza Vaccine as a Nasal Model for Influenza Infection

Influenza

United States
Karolinska University Hospital

Completed

Prevalence of Influenza RelAted Invasive Aspergillosis (PIRAIA)

Influenza, Human | Invasive Pulmonary Aspergillosis

Sweden
Vietnam Military Medical University
Vietstar Biomedical Research; Institute of Vaccines and Medical Biologicals...

Completed

This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in Vietnam

Influenza

Vietnam
Radboud University Medical Center
GlaxoSmithKline

Completed

Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX)

Influenza | Herpes Zoster

Netherlands
Guangdong Raynovent Biotech Co., Ltd

Completed

A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A

Influenza A

China
Henry M. Jackson Foundation for the Advancement...
National Institute of Allergy and Infectious Diseases (NIAID); Food and Drug... and other collaborators

Active, not recruiting

A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED)

Influenza | Influenza-like Illness | Influenza Vaccines

United States
Robert J. Pignolo
Genome Protection, Inc

Completed

Entolimod on Immunosenescence in Healthy Geriatric Subjects Receiving Influenza Vaccination

Healthy

United States
AstraZeneca
Amgen

Completed

Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma (VECTOR)

Moderate to Severe Asthma

United States
University of Louisville
Centers for Disease Control and Prevention

Completed

Rapid Empiric Treatment With Oseltamivir Study (RETOS) (RETOS)

Pneumonia | Influenza

United States
FluGen Inc
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Safety and Immunogenicity of the Sing2016 M2SR H3N2 Monovalent Influenza Vaccine in Adults Ages 50 to 85 Years Old

Influenza Vaccine

United States
Sanofi Pasteur, a Sanofi Company

Terminated

Study to Evaluate the Effectiveness of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Adults 65 Years of Age and Older

Influenza (Healthy Volunteers)

Finland
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine

Coronavirus Disease 2019

China
Tor Biering-Sørensen
Sanofi Pasteur, a Sanofi Company; Statens Serum Institut

Completed

Nationwide Utilization of Danish Government Electronic Letter System for Increasing InFLUenza Vaccine Uptake (NUDGE-FLU)

Influenza | Behavior and Behavior Mechanisms

Denmark
CureVac
GlaxoSmithKline

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVSQIV in Healthy Adults

Influenza

Panama
Cocrystal Pharma, Inc.
Cocrystal Pharma Australia Pty Ltd.; Linear Clinical Research

Completed

CC-42344 Safety Study in Healthy Participants

Influenza A

Australia
Pfizer

Completed

This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times.

COVID-19 | Influenza, Human

United States
St. Petersburg Research Institute of Vaccines and...

Completed

Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine

Vaccine Reaction | Influenza | Influenza, Human | Vaccination; Infection | Influenza Viral Infections

Russian Federation
Pneumagen Ltd.

Completed

Safety, Tolerability and Prophylactic Antiviral Activity of Neumifil Against Influenza Via a Human Viral Challenge Model

Influenza Viral Infections

United Kingdom
George Washington University

Completed

Immune Response to Seasonal Influenza Vaccine in HIV Infected Individuals

Influenza, Human | Human Immunodeficiency Virus I Infection

United States
ModernaTX, Inc.

Active, not recruiting

A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults

Seasonal Influenza

United States
Mayo Clinic
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Gene Signatures of Influenza Vaccine Responses in Older Adults

Influenza

United States
University of California, Los Angeles
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Patient Portal Flu Vaccine Reminders (5)

Respiratory Tract Infections | Influenza

United States
Novavax

Completed

Phase 3 Pivotal Trial of NanoFlu™ in Older Adults

Influenza, Human

United States
Novartis Vaccines

Completed

Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2011-2012

Seasonal Influenza

Italy
Sanofi

Completed

Postmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra®) in Subjects Aged 6 to 35 Months

Influenza

Korea, Republic of
Groupe Hospitalier Paris Saint Joseph

Completed

Evaluation of the Alere i Influenza A&B Nucleic Acid Amplification Versus Xpert Flu/RSV

Influenza

France
Public Health England

Withdrawn

Childhood Influenza Immunisation Invitation Trial in Schools

Influenza, Human
Livzon Pharmaceutical Group Inc.

Active, not recruiting

Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase III (COVID-19)

COVID-19 Pandemic

Philippines, Indonesia, Russian Federation
Marshfield Clinic Research Foundation
Centers for Disease Control and Prevention

Active, not recruiting

Randomized Influenza Vaccine Evaluation of Immune Response (RIVER)

Influenza

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

The Influence of Chronic CMV Infection on Influenza Vaccine Responses (SLVP025)

Influenza | Cytomegalovirus Infections

United States
Immunovative Therapies, Ltd.
Mirror Biologics, Inc.

Completed

Universal Anti-Viral Vaccine for Healthy Elderly Adults (ALLOPRIME)

Virus Diseases | Pneumonia | Influenza, Human | COVID-19 Respiratory Infection | ARDS, Human | RSV Pneumonia

United States
Pediatric Clinical Research Platform
University of Lausanne Hospitals

Completed

Impact of the Qatar 2022 FIFA World Cup on PED Use and Misuse Patterns

Emergencies | Pediatric ALL | Epidemic Disease | Electronic Medical Record

Switzerland
Butantan Institute

Completed

Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza (Xo_Gripe)

Influenza | Acute Respiratory Infection

Brazil
Sciensano
Institute of Tropical Medicine, Belgium; Université Libre de Bruxelles; Mensura...

Completed

Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection (PICOV)

COVID-19 | Influenza, Human | SARS Virus | Espiratory Tract Infections

Belgium
Canadian Immunization Research Network
CHU de Quebec-Universite Laval; McGill University Health Centre/Research Institute... and other collaborators

Completed

CT18 Infant Influenza Priming Study in Vaccine Naive Infants

Influenza

Canada
Seqirus
Novartis Vaccines

Completed

Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.

Influenza Virus

United States, Canada, Finland, Italy, Mexico, Philippines, Poland, Puerto Rico, Spain, Taiwan, Thailand
Sanofi Pasteur, a Sanofi Company

Completed

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2021/22

Influenza (Healthy Volunteers)

Germany, Finland
Henry M. Jackson Foundation for the Advancement...
National Institute of Allergy and Infectious Diseases (NIAID); Infectious Diseases...

Completed

Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons

HIV Infections | Influenza

United States
Insight Therapeutics, LLC
Brown University; Seqirus

Completed

Adjuvanted Influenza Vaccination Year 2 Follow-On Survey

Influenza | Influenza, Human | Influenza-like Illness

United States
University Hospital, Basel, Switzerland

Completed

Prospective System Analysis of the Seasonal Influenza Virus Transmissions and Evolution in the City of Basel Basel

Influenza
Insight Therapeutics, LLC
Brown University; Sanofi Pasteur, a Sanofi Company; Case Western Reserve University

Active, not recruiting

Recombinant Influenza Vaccination in U.S. Nursing Homes

Influenza | Influenza, Human | Influenza -Like Illness

United States
Insight Therapeutics, LLC
Brown University; Case Western Reserve University; Seqirus

Completed

Adjuvanted Influenza Vaccination in U.S. Nursing Homes

Influenza | Influenza-like Illness

United States
Insight Therapeutics, LLC
Brown University; Genentech, Inc.; Case Western Reserve University

Active, not recruiting

Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks

Influenza | Influenza, Human | Influenza -Like Illness

United States
Seqirus

Completed

Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine (QIV) in Children Previously Vaccinated in Trial V118_05

Influenza

United States, Finland
Poolbeg Pharma plc

Completed

Effects of p38 MAPK Inhibitor POLB 001 on in Vivo LPS Challenge Responses

Influenza, Human

Netherlands
BiondVax Pharmaceuticals ltd.

Completed

A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001)

Healthy

Israel
Kaiser Permanente
Sanofi Pasteur, a Sanofi Company

Completed

Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 Years

Stroke | Pneumonia | Influenza | Congestive Heart Failure | Acute Myocardial Infarction | Lower Respiratory Tract Infection

United States
Lokman Hekim Üniversitesi

Completed

Seasonal Influenza and Pneumococcal Vaccination in the Elderly

Pneumonia | Influenza | Immunization; Infection | Vaccine Refusal

Turkey
National Institute of Allergy and Infectious Diseases...

Completed

Dose, Safety, Tolerability and Immunogenicity of an Influenza H10 Stabilized Stem Ferritin Vaccine, VRC-FLUNPF0103-00-VP, in Healthy Adults

Influenza

United States
Ology Bioservices

Completed

Reverse Genetic H9N2 Influenza Vaccine Study in Adults

Influenza

United States

Search clinical trials for: Influenza Human

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations